Regulatory News
Wednesday, July 27, 2016
BRIEF-Teva gets U.S. FTC clearance for Actavis Generics deal
* Teva receives clearance from the U.S. Federal Trade
Commission for Actavis Generics acquisition
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment